AMSTERDAM (AP) — AMSTERDAM (AP) — UniQure NV (QURE) on Tuesday reported a loss of $65.6 million in its first quarter.
The Amsterdam-based company said it had a loss of $1.36 per share.
The results missed Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of $1.31 per share.
The human gene therapy company posted revenue of $8.5 million in the period, beating Street forecasts. Four analysts surveyed by Zacks expected $2.6 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on QURE at https://www.zacks.com/ap/QURE
Copyright © 2024 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
